Pramlintide, a Synthetic Analog of Human Amylin, Improves the Metabolic Profile of Patients With Type 2 Diabetes Using Insulin - Concepedia

Concepedia

Publication | Closed Access

Pramlintide, a Synthetic Analog of Human Amylin, Improves the Metabolic Profile of Patients With Type 2 Diabetes Using Insulin

86

Citations

0

References

1998

Year

Robert G. Thompson, Leeanne L. Pearson, Steven Schoenfeld, Orville Kolterman

Abstract

Reductions in serum fructosamine, plasma total and LDL cholesterol concentrations, and HbA1c support the hypothesis that pramlintide may improve metabolic control in patients with type 2 diabetes using insulin.